In Phase A, individuals will get different doses and schedules of oral ABBV-744 tablet to discover safe dosing regimen. More contributors is going to be enrolled within the identified monotherapy dosign regimen. In Segment B, participants will obtain oral ruxolitinib and ABBV-744 might be offered as "incorporate-on" therapy. In Section https://edwardt999fqz1.frewwebs.com/profile